DNA Vaccines Market: By Type, By Application, By Technology and Region Forecast 2019-2030

download arrow download arrow Download Sample
settings arrow settings arrow email us

DNA Vaccines Market Size, Share, Growth, Trends, and Global Industry Analysis: By Type (Animal DNA vaccine and Human DNA vaccine), By Application (Human disease and Veterinary disease), By Technology (Plasmid DNA vaccines and Plasmid DNA delivery) and Region Forecast 2019-2030

checked icon checked icon arrow_drop_down
checked icon Single User License $4400 $3520
checked icon Multiple User License $6600 $5280
checked icon Corporate User License $8900 $7120

DNA Vaccines Market size is valued at US$ 453.4 million in 2023 and is poised to grow at a CAGR of 6.6% from 2024 - 2030. DNA vaccination is a method for shielding an individual against illness by vaccinating it with genetically engineered DNA, so cells directly manufacture an antigen, ensuing in a defensive immunological response. It contains delivering genes or fragments of it, training immunogenic antigens to the cells of the host by utilizing DNA plasmids as a vector. This method encourages both cell-mediated and humoral immune responses efficiently. DNA vaccines are third-generation vaccines precisely designed to overcome the unsolicited possessions of conventional vaccines. The surge in the vulnerability of the population to communicable diseases and the growth in a number of antibiotic-resistant pathogens have created the necessity for low-cost and effective vaccination, which would deliver immunity for a longer time period. The global market provides a detailed overview of the market size, and that can be segmented by type, by application, and by technology. By type, the market growth has been segmented into Animal DNA vaccine and Human DNA vaccine. The animal DNA vaccine segment is likely to be the significant growing segment in terms of type. Based on Application, the market is segmented into Human application and Veterinary applications. Among these, the Human application segment is expected to have a significant growing market during the forecast period 2024-2030. Based on the technology, the market is segmented Plasmid DNA vaccines and Plasmid DNA delivery. The Plasmid DNA Preparation delivery segment is expected to have a significant share in 2021.

Key Developments

  • In August 2021, the three-dose ZyCoV-D vaccine  protected against symptomatic disease in 66% of those vaccinated

summary download arrow Download Sample

Dna Vaccines Market Summary

Study Period

2025-2031

Base Year

2024

CAGR

6.6%

Largest Market

North-America

Fastest Growing Market

Europe

DNA Vaccines Market Dynamics

The increase in the prevalence of infectious and cancer diseases in humans and animals increase in the need for DNA vaccines due to their advantages are anticipated to propel the market growth over the forecast years. Moreover, the surge in number of antibiotics resistant pathogens is burgeoning the market growth over the forecast years.

Dna Vaccines Market Segmentation Analysis

Report Benchmarks

Details

Report Study Period

2025-2031

Market Size in 2023

US$ 453.4 million

Market CAGR

6.6%

By Type

  • Animal DNA vaccine
  • Human DNA vaccine

By Technology

  • Plasmid DNA vaccines
  • Plasmid DNA delivery

By Application

  • Human disease
  • Veterinary disease

By Region

  • North America (U.S., Canada)
  • Europe (Germany, U.K., France, Italy, Russia, Spain, Rest of Europe)
  • Asia-Pacific (China, India, Japan, Australia, Southeast Asia, Rest of Asia Pacific)
  • Latin America (Mexico, Brazil, Argentina, Columbia, Rest of Latin America)
  • Middle East & Africa (GCC, Egypt, Nigeria, South Africa, Rest of Middle East and Africa)

Key Features of the Report

  • The dna vaccines market report provides granular level information about the market size, regional market share, historic market (2019 to 2023) and forecast (2024 to 2030)
  • The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments and startup’s details that are actively working in the market
  • The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario
  • The report analyses the impact of socio-political environment through PESTLE Analysis and competition through Porter’s Five Force Analysis

Download Free Sample Report

I accept the Terms and Conditions,Disclaimers, GDPR Policy

Frequently Asked Questions

DNA vaccines market size is valued at US$ 453.4 million in 2023 and is poised to grow at a CAGR of 6.6% from 2024 - 2030.

lack of immunogenicity related with DNA vaccines.

On February 2022, Alvea launched a shelf-stable DNA vaccine against the new SARS- CoV-2.

Easy DNA vaccine product approval and presence of key players in these regions

Author image

Author

Muni Kumar Meravath

Muni Kumar Meravath is a seasoned Healthcare Market Research Analyst with over 6 years of experience in the healthc.....

1.Executive Summary
2.Global Dna Vaccines Market Introduction 
2.1.Global Dna Vaccines Market  - Taxonomy
2.2.Global Dna Vaccines Market  - Definitions
2.2.1.Type
2.2.2.Technology
2.2.3.Application
2.2.4.Region
3.Global Dna Vaccines Market Dynamics
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Product Landscape
3.6. New Product Launches
3.7. Impact of COVID 19 on Market
4.Global Dna Vaccines Market Analysis, 2020 - 2024 and Forecast 2025 - 2031
4.1.  Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million)
4.2.  Year-Over-Year (Y-o-Y) Growth Analysis (%) 
4.3.  Market Opportunity Analysis 
5.Global Dna Vaccines Market  By Type, 2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million)
5.1. Animal DNA vaccine
5.1.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million)
5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.1.3. Market Opportunity Analysis 
5.2. Human DNA vaccine
5.2.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million)
5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.2.3. Market Opportunity Analysis 
6.Global Dna Vaccines Market  By Technology, 2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million)
6.1. Plasmid DNA vaccines
6.1.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million)
6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.1.3. Market Opportunity Analysis 
6.2. Plasmid DNA delivery
6.2.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million)
6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.2.3. Market Opportunity Analysis 
7.Global Dna Vaccines Market  By Application, 2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million)
7.1. Human disease
7.1.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million)
7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.1.3. Market Opportunity Analysis 
7.2. Veterinary disease
7.2.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million)
7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.2.3. Market Opportunity Analysis 
8.Global Dna Vaccines Market  By Region, 2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million)
8.1. North America
8.1.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million)
8.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.1.3. Market Opportunity Analysis 
8.2. Europe
8.2.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million)
8.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.2.3. Market Opportunity Analysis 
8.3. Asia Pacific (APAC)
8.3.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million)
8.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.3.3. Market Opportunity Analysis 
8.4. Middle East and Africa (MEA)
8.4.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million)
8.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.4.3. Market Opportunity Analysis 
8.5. Latin America
8.5.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million)
8.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.5.3. Market Opportunity Analysis 
9.North America Dna Vaccines Market ,2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million)
9.1. Type Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.1.1.Animal DNA vaccine
9.1.2.Human DNA vaccine
9.2.  Technology Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.2.1.Plasmid DNA vaccines
9.2.2.Plasmid DNA delivery
9.3.  Application Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.3.1.Human disease
9.3.2.Veterinary disease
9.4.  Country Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.4.1.United States of America (USA)
9.4.2.Canada
10.Europe Dna Vaccines Market ,2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million)
10.1. Type Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.1.1.Animal DNA vaccine
10.1.2.Human DNA vaccine
10.2.  Technology Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.2.1.Plasmid DNA vaccines
10.2.2.Plasmid DNA delivery
10.3.  Application Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.3.1.Human disease
10.3.2.Veterinary disease
10.4.  Country Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.4.1.Germany
10.4.2.France
10.4.3.Italy
10.4.4.United Kingdom (UK)
10.4.5.Spain
11.Asia Pacific (APAC) Dna Vaccines Market ,2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million)
11.1. Type Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.1.1.Animal DNA vaccine
11.1.2.Human DNA vaccine
11.2.  Technology Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.2.1.Plasmid DNA vaccines
11.2.2.Plasmid DNA delivery
11.3.  Application Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.3.1.Human disease
11.3.2.Veterinary disease
11.4.  Country Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.4.1.China
11.4.2.India
11.4.3.Australia and New Zealand (ANZ)
11.4.4.Japan
11.4.5.Rest of APAC
12.Middle East and Africa (MEA) Dna Vaccines Market ,2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million)
12.1. Type Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.1.1.Animal DNA vaccine
12.1.2.Human DNA vaccine
12.2.  Technology Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.2.1.Plasmid DNA vaccines
12.2.2.Plasmid DNA delivery
12.3.  Application Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.3.1.Human disease
12.3.2.Veterinary disease
12.4.  Country Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.4.1.GCC Countries
12.4.2.South Africa
12.4.3.Rest of MEA
13.Latin America Dna Vaccines Market ,2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million)
13.1. Type Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.1.1.Animal DNA vaccine
13.1.2.Human DNA vaccine
13.2.  Technology Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.2.1.Plasmid DNA vaccines
13.2.2.Plasmid DNA delivery
13.3.  Application Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.3.1.Human disease
13.3.2.Veterinary disease
13.4.  Country Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.4.1.Brazil
13.4.2.Mexico
13.4.3.Rest of LA
14. Competition Landscape
14.1.  Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) 
14.2.1.Merck & Co., Inc. (U.S.),
14.2.2.Sanofi Pasteur SA (France),
14.2.3.Astellas Pharma Inc. (Japan)
14.2.4.GlaxoSmithKline, plc (U.K.),
14.2.5.Pfizer, Inc. (U.S)
14.2.6.CSL Limited (Australia),
14.2.7.Emergent BioSolutions, Inc. (U.S.),
14.2.8.Panacea Biotec (India)
14.2.9.Protein Sciences Corporation (U.S)
14.2.10.Bavarian Nordic (Denmark)
15. Research Methodology 
16. Appendix and Abbreviations 

Key Market Players

  • Merck & Co., Inc. (U.S.),
  • Sanofi Pasteur SA (France),
  • Astellas Pharma Inc. (Japan)
  • GlaxoSmithKline, plc (U.K.),
  • Pfizer, Inc. (U.S)
  • CSL Limited (Australia),
  • Emergent BioSolutions, Inc. (U.S.),
  • Panacea Biotec (India)
  • Protein Sciences Corporation (U.S)
  • Bavarian Nordic (Denmark)

Related Industry Reports

Global Rna Vaccines Pipeline Analysis Market

Swine Vaccines Market